Simultaneous primary hepatocellular carcinoma and neuroendocrine carcinoma

Dig Liver Dis. 2021 Jun;53(6):792-793. doi: 10.1016/j.dld.2020.05.049. Epub 2020 Jun 24.

Authors

Hiroaki Mita¹, Yasushi Adachi², Yoshifumi Ishii³, Takao Endo¹

Affiliations

¹ Division of Gastroenterology, Department of Internal Medicine, Sapporo Shirakaba-dai Hospital, 2-18 Tsukisamu-Higashi, Toyohira-ku, Sapporo 062-0052, Japan.
² Division of Gastroenterology, Department of Internal Medicine, Sapporo Shirakaba-dai Hospital, 2-18 Tsukisamu-Higashi, Toyohira-ku, Sapporo 062-0052, Japan. Electronic address: yadachi@sapmed.ac.jp.
³ Pathology, Sapporo Shirakaba-dai Hospital, Sapporo, Japan.

PMID: 32593515
DOI: 10.1016/j.dld.2020.05.049

No abstract available

Keywords: Differential algorithm; Immunohistochemical examination; Neuroendocrine Carcinoma; transcription factors.

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Carcinoma, Hepatocellular / diagnosis
Carcinoma, Hepatocellular / pathology*
Carcinoma, Neuroendocrine / diagnosis
Carcinoma, Neuroendocrine / pathology*
Fatal Outcome
Female
Humans
Liver Neoplasms / diagnosis
Liver Neoplasms / pathology*
Neoplasms, Multiple Primary
Pancreatic Neoplasms / diagnosis
Pancreatic Neoplasms / pathology*